Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Fibroblast Growth Factor Research

9 ta ish

  1. Oxidative damage to hyaluronan–CD44 interactions as an underlying mechanism of action of oxidative stress-inducing cancer therapy

    Maksudbek Yusupov, Angela Privat‐Maldonado, Rodrigo M. Cordeiro +5

    MaqolaOchiq kirishProteoglycans and glycosaminoglycans researchRedox Biology202111 iqtibos
    ABI

  2. MAIN MOLECULAR MECHANISMS OF CARCINOGENESIS INDUCED BY HUMAN PAPILLOMAVIRUS

    D. Polatova, А. Yu. Madaminov

    MaqolaOchiq kirishProteoglycans and glycosaminoglycans researchMalignant tumours20210 iqtibos
    ABI

  3. Analysis of Associative Relationship of Allelic and Genotypical Variants of Polymorphism Rs 2010963 of the VEGFA Gene with Formation and Development of Ronchopathy

    Khasanov Ulugbek Saidakramovich, Sharipov Sanjar Salomovich

    MaqolaOchiq kirishObstructive Sleep Apnea ResearchInternational Journal of Advanced Dental Sciences and Technology20210 iqtibos
    ABI

  4. Analysis of Associative Relationship of Allelic and Genotypical Variants of Polymorphism Rs 2010963 of the VEGFA Gene with Formation and Development of Ronchopathy

    Khasanov Ulugbek Saidakramovich, Sharipov Sanjar Salomovich

    MaqolaObstructive Sleep Apnea ResearchInternational Journal of Advanced Dental Sciences and Technology20210 iqtibos
    ABI

  5. WAYS TO IMPROVE THE EFFECTIVENESS OF CHEMOTHERAPY PATIENTS WITH LARYNGEAL CANCER, WITH MALIGNANT TUMORS OF THE NOSE AND PARANASAL SINUSES

    Ulmasov Firdavs Gayratovich, Rakhimov Zhakhongir Khotamovich, Nasretdinova Makhzuna Takhsinovna

    MaqolaOchiq kirishHead and Neck Surgical OncologyThe American Journal of Medical Sciences and Pharmaceutical Research20240 iqtibos
    ABI

  6. Nivolumab Combined with Chemotherapy in FGFR2 and PD-L1 Co- Expressing Metastatic Gastric Cancer: A Prospective Phase 2 NIVOFGFR2 Study

    Ilya Tsimafeyeu, Gunel Musayeva, Samira Mahmudova +4

    PreprintFibroblast Growth Factor ResearchResearch Square20240 iqtibos
    ABI

  7. IL-6 AND FGF-23 AS EARLY BIOMARKERS OF LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE RISK IN DIABETES MELLITUS

    Volha Vasilkova, Tatsiana Mokhort, Natalia Khudiakova +2

    MaqolaAdipokines, Inflammation, and Metabolic DiseasesJournal of Hypertension20260 iqtibos
    ABI

  8. CHARACTERISTICS OF THE COURSE AND TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC LIVER DISEASE

    Dilorom Kamardinovna Najmutdinova, Farzona Jahongir qizi Aripdjanova

    MaqolaOchiq kirishLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  9. CHARACTERISTICS OF THE COURSE AND TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND METABOLIC LIVER DISEASE

    Dilorom Kamardinovna Najmutdinova, Farzona Jahongir qizi Aripdjanova

    MaqolaLiver Disease Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI